Pulling SEC filings + quote and writing the call…

OLB GROUP, INC.
Next earnings Aug 17, 2026 · consensus $-0.09 EPS, $2.08M rev
Melting nano-cap FinTech: revenue down 72% in two years, $15.8K cash, 428% dilution, and a sub-$1 stock facing delisting — uninvestable.
Cash & equivalents $15.8K · FY2025
OLB is a $4.5M nano-cap whose core merchant-services business is disintegrating, not building. Revenue has collapsed from $30.6M (FY2023) to $12.8M (FY2024) to $8.68M (FY2025) — a 72% two-year decline and -32.4% in the latest year — while the company has never earned a profit in the five years shown, with cumulative retained-earnings deficit of -$74.4M. The narrowing net loss to -$5.87M looks like progress until you see it's driven by shrinking the business, not fixing unit economics: gross margin is 0.7%, operating margin -59.5%, and net margin -67.7%. The MD&A touts eVance processing '$100,000,000 in gross transactions monthly,' but that headline volume converts to almost no gross profit — the company explicitly notes revenue from SecurePay transactions 'is limited.' This is a business that moves large payment volumes and keeps almost none of it.
The balance sheet is the disqualifier. Cash and equivalents are $15.8K — not a typo, fifteen thousand dollars — against $7.69M of current liabilities and only $1.05M of current assets, a ~$6.6M working-capital hole. Stockholders' equity of $4.61M is thin and, with -$1.33M operating cash flow, the company cannot self-fund. It has been plugging the gap by printing stock: shares outstanding rose 428% year-over-year, and the MD&A discloses ongoing unregistered issuances. At $0.36 the stock is already deep below NASDAQ's $1.00 minimum bid, so continued dilution and delisting risk compound each other — existing holders get diluted toward zero while the listing itself is in jeopardy.
Is OLB a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $16.7M | $30.4M | $30.6M | $12.8M | $8.68M |
| Gross profit | — | — | — | — | — |
| Operating income | -$4.76M | -$8.17M | -$23.5M | -$11.7M | -$5.17M |
| Net income | -$4.98M | -$7.79M | -$23.3M | -$11.2M | -$5.87M |
| Diluted EPS | — | -$0.56 | -$15.33 | -$6.10 | -$1.74 |
| Net margin | -29.8% | -25.6% | -76.1% | -87.4% | -67.7% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Notice it could not file Q1 10-Q on time — reporting-timeliness red flag
Notice it could not file Q1 10-Q on time — reporting-timeliness red flag
Registration statement (DMINT spin-off / resale) — sets up more shares for market
Late-filing notice for the FY25 annual report — timeliness red flag
Late-filing notice for the FY25 annual report — timeliness red flag
New financing deal with unregistered share issuance — further dilution of tiny 12.5M float
Item 3.01 Nasdaq listing-deficiency notice — delisting risk for OLB
Item 3.01 Nasdaq listing-deficiency notice — delisting risk for OLB
Another financing agreement with unregistered equity sale — more dilution
Sources: SEC EDGAR (CIK 0001314196, latest 10-Q filed 2026-05-18) · EODHD · Proprietary analysis · as of 7/4/2026, 10:01:19 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 6:01 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2025-06-02 | RACHEL BOULDS CPA, PLLC Chief Financial Officer | Acquired (J) | 35.0K @ $1.31 | $45.9K |
| 2024-01-16 | YAKOV RONNY Chairman and CEO | Buy | 784K @ $0.77 | $600K |
| 2024-01-16 | Smith Patrick G Vice President | Buy | 392K @ $0.77 | $300K |
| 2024-01-12 | Smith Patrick G Vice President - Finance | Exercise | 381K @ $0.00 | $38.11 |
| 2024-01-12 | YAKOV RONNY Chairman and CEO | Exercise | 420K @ $0.00 | $42.00 |
| 2023-07-21 | YAKOV RONNY Chairman and CEO | Buy | 100.00 @ $1.02 | $102.00 |
| 2023-07-21 | YAKOV RONNY Chairman and CEO | Buy | 15.00 @ $1.02 | $15.30 |
| 2023-07-21 | YAKOV RONNY Chairman and CEO | Buy | 500.00 @ $1.01 | $505.00 |
| 2023-07-21 | YAKOV RONNY Chairman and CEO | Buy | 1.00K @ $1.02 | $1.02K |
| 2023-07-21 | YAKOV RONNY Chairman and CEO | Buy | 300.00 @ $0.99 | $297.00 |
| 2023-07-21 | YAKOV RONNY Chairman and CEO | Buy | 500.00 @ $0.97 | $485.50 |
| 2023-07-21 | YAKOV RONNY Chairman and CEO | Buy | 350.00 @ $0.99 | $346.36 |
1195 tracked peers · median